S&P 500
7,718.94
-86.51
-1.11%
Dow
51,621.48
-48.62
-0.09%
Nasdaq
26,692.87
-511.51
-1.88%
NYSE Composite
23,865.42
-119.58
-0.50%
Russell 2000
2,729.53
-53.84
-1.93%
VIX
16.87
+1.60
+10.48%
LQDA · Liquidia Corporation
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$33.97
+7.16
(+26.71%)
● At close: October 14 at 4:00:00 PM EDT
$33.65
-0.29
(-0.85%)
After-Hours:
5:27:48 PM EDT
DAY'S RANGE
$33.97
$33.18
$38.58
52-WEEK RANGE
$33.97
$21.94
$93.61
What's happening
- LQDA is up 26.71% today, trading at $33.97. — Live quote
- Volume today (556,725) is well below its 3-month average of 2,525,620. (Finnhub fundamentals)
- Reports earnings on 2026-11-10 (before market open), 27 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $0.74 actual vs. $0.76 estimated (-2.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 6
Hold 4
Sell 0
Strong sell 0
Aggregate ratings for 2026-09-01 (15 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
LQDA
-19.77%
vs S&P 500
-33.88%
1-YEAR RETURN
LQDA
+19.32%
vs S&P 500
+0.16%
6-MONTH RETURN
LQDA
-27.55%
3-MONTH RETURN
LQDA
-61.14%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.74
Est. $0.76
MISS -2.3%
2026-04-26 (Q1 2026)
$0.52
Est. $0.42
BEAT +24.3%
2026-01-26 (Q4 2025)
$0.17
Est. $0.18
MISS -7.6%
2025-10-26 (Q3 2025)
$-0.04
Est. $-0.41
BEAT +90.2%
Valuation Measures & Ratios
Enterprise Value4$2.29B
Forward P/E514.34
PEG Ratio6—
Price / Sales (TTM1)5.32
Price / Book736.34
EV4 / Revenue5.08
EV4 / EBITDA13.56
Profit Margin30.74%
Operating Margin37.39%
Return on Equity (ROE8)149.64%
Return on Assets (ROA9)36.30%
Avg Volume (3M)2,525,620
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $8.05B | $3.83B | $2.01B | $1.06B | $1.26B |
| P/E | 97.59 | -125.21 | -17.54 | -7.58 | -9.80 |
| Price/Sales | 21.89 | 19.25 | 28.39 | 52.78 | 88.45 |
| Price/Book | 41.25 | 35.31 | 91.08 | 69.72 | 25.26 |
| EV/Revenue | 21.12 | 18.13 | 26.16 | 44.14 | 76.49 |
| EV/EBITDA | 68.75 | -453.95 | -18.79 | — | — |
| ROE | 42.27% | -28.20% | -519.27% | -919.38% | -257.78% |
| ROA | 15.80% | -7.63% | -41.49% | -54.25% | -56.35% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short12,640,721
Change from Prior Settlement+2.12%
% of Float—
Days to Cover (Short Ratio)3.84
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 1842.7% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 30.7%. Finnhub fundamentals ↗
- Trailing 52-week price return is +19.3%. Finnhub market metrics ↗
Potential concerns
- Latest SEC filing is Form 8-K, filed 2026-10-14; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on LQDA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $171.7M | $132.9M | $54.3M | $8.8M | $3.1M | $4.4M | $3.7M | $3.0M |
| Operating income | $85.5M | $61.5M | $1.8M | -$37.5M | -$35.4M | -$29.2M | -$27.2M | -$28.8M |
| Net income | $74.7M | $52.9M | -$3.5M | -$41.6M | -$38.4M | -$31.0M | -$28.7M | -$30.1M |
| EPS (diluted) | $0.74 | $0.52 | $-0.04 | $-0.49 | $-0.45 | $-0.40 | $-0.38 | $-0.40 |
| EPS (basic) | $0.84 | $0.60 | $-0.04 | $-0.49 | $-0.45 | $-0.40 | $-0.38 | $-0.40 |
| Operating margin | $50 | $46 | $3 | -$424 | -$1.1K | -$656 | -$743 | -$969 |
| Net margin | $44 | $40 | -$7 | -$471 | -$1.2K | -$698 | -$783 | -$1.0K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $521.9M | $401.5M | $327.9M | $276.0M | $257.4M | $227.4M | $230.3M | $252.9M |
| Total liabilities | $326.8M | $293.0M | $283.2M | $253.9M | $242.2M | $177.7M | $150.9M | $142.4M |
| Stockholders' equity | $195.1M | $108.6M | $44.7M | $22.1M | $15.2M | $49.7M | $79.4M | $112.8M |
| Total current assets | $437.7M | $333.1M | $273.4M | $226.7M | $195.6M | $177.2M | $185.1M | $214.2M |
| Total current liabilities | $189.3M | $149.7M | $135.8M | $102.9M | $78.4M | $60.5M | $41.8M | $33.8M |
| Cash & equivalents | $284.2M | $222.8M | $190.7M | $157.5M | $173.4M | $169.8M | $176.5M | $204.4M |
| Accounts receivable | $108.6M | $74.2M | $54.1M | $36.0M | $10.0M | $1.2M | $2.7M | $4.2M |
| Inventory | $36.2M | $28.5M | $23.8M | $24.5M | $6.4M | $1.3M | $241.0K | $38.0K |
| Property, plant & equipment | $34.6M | $20.8M | $11.8M | $10.7M | $9.5M | $8.5M | $8.3M | $7.8M |
| Goodwill | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M |
| Intangible assets | $2.8M | $2.9M | $3.0M | $3.0M | $3.1M | $3.1M | $3.2M | $3.2M |
| Other non-current assets | $19.3M | $16.9M | $13.2M | $9.0M | $22.4M | $15.5M | $10.9M | $7.8M |
| Accounts payable | $12.7M | $11.0M | $3.7M | $6.0M | $11.3M | $8.7M | $4.7M | $2.3M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $89.0K | $88.0K | $87.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K |
| Retained earnings | -$498.7M | -$573.5M | -$626.3M | -$640.9M | -$637.3M | -$595.8M | -$557.4M | -$521.1M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $80.2M | $53.0M | $44.2M | -$9.8M | -$39.5M | -$30.7M | -$20.8M | -$25.1M |
| Investing cash flow | -$12.2M | -$2.8M | -$4.0M | -$911.0K | -$1.1M | -$330.0K | -$4.8M | -$1.7M |
| Financing cash flow | -$6.6M | -$18.1M | -$7.0M | -$5.2M | $47.7M | $24.3M | -$2.3M | $98.1M |
| Free cash flow | $69.0M | $50.2M | $42.2M | -$10.7M | -$40.5M | -$31.0M | -$22.1M | -$26.8M |
| Capital expenditures | $11.2M | $2.8M | $2.0M | $911.0K | $1.1M | $330.0K | $1.3M | $1.7M |
| Depreciation & amortization | $400.0K | $497.0K | $320.0K | $476.0K | $281.0K | $451.0K | $518.0K | $610.0K |
| Share-based compensation | $10.4M | $9.2M | $7.2M | $7.9M | $6.9M | $7.4M | $5.0M | $4.9M |
| Change in inventory | $7.5M | $4.6M | -$943.0K | $18.0M | $4.9M | $1.1M | $203.0K | -$7.2M |
| Change in accounts payable | -$1.2M | $562.0K | -$2.0M | -$6.0M | $1.9M | $3.4M | $2.6M | -$3.4M |
| Debt issued | $0 | $0 | $0 | $0 | $50.0M | $25.0M | $0 | $32.5M |
| Debt repaid | $8.1M | $20.0M | $8.1M | $8.1M | $2.9M | $2.1M | $2.1M | $1.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $158.3M | $14.0M | $17.5M | $15.9M | $12.9M |
| Operating income | -$51.4M | -$121.3M | -$73.4M | -$38.8M | -$33.8M |
| Net income | -$68.9M | -$128.3M | -$78.5M | -$41.0M | -$34.6M |
| EPS (diluted) | $-0.80 | $-1.63 | $-1.21 | $-0.67 | $-0.70 |
| EPS (basic) | $-0.80 | $-1.63 | $-1.21 | $-0.67 | $-0.70 |
| Operating margin | -$32 | -$867 | -$420 | -$243 | -$263 |
| Net margin | -$44 | -$917 | -$449 | -$257 | -$269 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $327.9M | $230.3M | $118.3M | $129.2M | $93.7M |
| Total liabilities | $283.2M | $150.9M | $71.0M | $38.8M | $28.5M |
| Stockholders' equity | $44.7M | $79.4M | $47.3M | $90.4M | $65.3M |
| Total current assets | $273.4M | $185.1M | $89.9M | $99.8M | $61.3M |
| Total current liabilities | $135.8M | $41.8M | $18.6M | $8.8M | $7.3M |
| Cash & equivalents | $190.7M | $176.5M | $83.7M | $93.3M | $57.5M |
| Accounts receivable | $54.1M | $2.7M | $4.1M | $5.0M | $3.0M |
| Inventory | $23.8M | $241.0K | — | — | — |
| Property, plant & equipment | $11.8M | $8.3M | $4.5M | $4.2M | $5.0M |
| Goodwill | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M |
| Intangible assets | $3.0M | $3.2M | $3.4M | $3.7M | $4.4M |
| Other non-current assets | $13.2M | $10.9M | $287.0K | — | — |
| Accounts payable | $3.7M | $4.7M | $1.4M | $2.2M | $1.1M |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | — | $19.9M | $10.4M |
| Common stock & paid-in capital | $87.0K | $85.0K | $69.0K | $64.0K | $52.0K |
| Retained earnings | -$626.3M | -$557.4M | -$429.1M | -$350.6M | -$309.6M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$35.7M | -$93.4M | -$41.6M | -$28.6M | -$34.0M |
| Investing cash flow | -$6.3M | -$8.4M | -$11.3M | -$587.0K | -$107.0K |
| Financing cash flow | $59.7M | $194.7M | $43.2M | $65.0M | $26.3M |
| Free cash flow | -$40.0M | -$98.4M | -$42.9M | -$29.2M | -$34.1M |
| Capital expenditures | $4.3M | $4.9M | $1.3M | $592.0K | $107.0K |
| Depreciation & amortization | $1.5M | $2.2M | $2.2M | $3.6M | $5.6M |
| Share-based compensation | $29.5M | $18.8M | $10.1M | $9.3M | $6.7M |
| Change in inventory | $23.0M | $241.0K | — | — | — |
| Change in accounts payable | -$2.6M | $2.3M | -$1.2M | $814.0K | -$7.6M |
| Debt issued | $75.0M | $57.5M | $41.7M | $19.8M | $10.4M |
| Debt repaid | $21.1M | $4.9M | $21.7M | $10.5M | $10.4M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding LQDA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers69.5%
Shares Outstanding88,887,744
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,788,586 | $860.2M | 12.14% | +96.5% | 2026-08-07 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 8,365,038 | $666.9M | 9.41% | -3.4% | 2026-08-14 |
| Caligan Partners LP | 8,118,892 | $647.3M | 9.13% | +0.0% | 2026-08-14 |
| FINDELL CAPITAL MANAGEMENT LLC | 3,502,112 | $279.2M | 3.94% | +0.0% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,139,183 | $250.3M | 3.53% | +7.3% | 2026-06-30 |
| State Street Corp | 3,030,395 | $241.6M | 3.41% | +61.1% | 2026-08-07 |
| Opaleye Management Inc. | 2,447,500 | $195.1M | 2.75% | -3.8% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,121,290 | $169.2M | 2.39% | +10.0% | 2026-08-12 |
| Bank Of America Corp /De/ | 1,991,566 | $158.8M | 2.24% | -12.9% | 2026-08-14 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,940,364 | $154.7K | 2.18% | +103.6% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,532,151 | $122.2M | 1.72% | +142.2% | 2026-06-30 |
| Caprock Group, LLC | 1,409,759 | $112.4M | 1.59% | +3.1% | 2026-07-27 |
| MPM BioImpact LLC | 1,386,174 | $110.5M | 1.56% | -1.4% | 2026-08-14 |
| D. E. Shaw & Co., Inc. | 1,267,706 | $101.1M | 1.43% | +45.2% | 2026-08-14 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,209,604 | $96.4M | 1.36% | +0.0% | 2026-08-12 |
| Goldman Sachs Group Inc | 958,892 | $76.5M | 1.08% | +18.1% | 2026-08-14 |
| Federated Hermes, Inc. | 816,187 | $65.1M | 0.92% | +86.0% | 2026-08-12 |
| Northern Trust Corp | 709,063 | $56.5M | 0.80% | +22.3% | 2026-08-12 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 674,033 | $53.7M | 0.76% | +21.0% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 674,033 | $53.7M | 0.76% | +0.0% | 2026-08-13 |
| Morgan Stanley | 658,441 | $52.5M | 0.74% | +91.0% | 2026-08-11 |
| BOOTHBAY FUND MANAGEMENT, LLC | 622,716 | $49.6M | 0.70% | -0.4% | 2026-08-14 |
| UBS Group AG | 606,558 | $48.4M | 0.68% | +192.7% | 2026-08-13 |
| FMR LLC | 595,629 | $47.5M | 0.67% | +2.3% | 2026-08-13 |
| AMERICAN CENTURY COMPANIES INC | 542,131 | $43.2M | 0.61% | +0.0% | 2026-08-12 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-07-10 to 2026-10-12
Recent transactions
- Insiders have net sold 932,797 shares over the last 182 days, across 0 purchases and 41 sales.
- Most recent: Schundler Russell (General Counsel) — Open market sale of 13,692 shares on 2026-10-12.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)932,797 sh(41 txns)
Net Shares-932,797
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Schundler Russell | General Counsel | Open market sale | 2026-10-12 | 13,692 |
| Saggar Rajeev | Chief Medical Officer | Open market sale | 2026-10-12 | 9,218 |
| Moomaw Scott | Chief Commercial Officer | Open market sale | 2026-10-12 | 8,863 |
| Krepp Sarah | Chief Human Resource Officer | Open market sale | 2026-10-12 | 5,245 |
| Khindri Sanjeev | Chief Development Officer | Open market sale | 2026-10-12 | 1,101 |
| Kaseta Michael | CFO and COO | Open market sale | 2026-10-12 | 18,938 |
| JEFFS ROGER | Chief Executive Officer | Open market sale | 2026-10-12 | 32,744 |
| Boyle Dana | Chief Accounting Officer | Open market sale | 2026-10-12 | 5,892 |
| Adair Jason | Chief Business Officer | Open market sale | 2026-10-12 | 7,301 |
| Bloch Stephen M | Director | Open market sale | 2026-10-05 | 235,477 |
| SINGH RAMAN | Director | Option exercise | 2026-09-14 | 8,468 |
| Rielly-Gauvin Katherine | Director | Option exercise | 2026-08-20 | 11,727 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-12 | Schundler Russell | General Counsel | Open market sale | 13,692 | $28.48 |
| 2026-10-12 | Saggar Rajeev | Chief Medical Officer | Open market sale | 9,218 | $28.48 |
| 2026-10-12 | Moomaw Scott | Chief Commercial Officer | Open market sale | 8,863 | $28.48 |
| 2026-10-12 | Krepp Sarah | Chief Human Resource Officer | Open market sale | 5,245 | $28.48 |
| 2026-10-12 | Khindri Sanjeev | Chief Development Officer | Open market sale | 1,101 | $28.48 |
| 2026-10-12 | Kaseta Michael | CFO and COO | Open market sale | 18,938 | $28.48 |
| 2026-10-12 | JEFFS ROGER | Chief Executive Officer | Open market sale | 32,744 | $28.48 |
| 2026-10-12 | Boyle Dana | Chief Accounting Officer | Open market sale | 5,892 | $28.48 |
| 2026-10-12 | Adair Jason | Chief Business Officer | Open market sale | 7,301 | $28.48 |
| 2026-10-09 | Schundler Russell | General Counsel | Option exercise | 3,758 | — |
| 2026-10-09 | Schundler Russell | General Counsel | Option exercise | 6,409 | — |
| 2026-10-09 | Saggar Rajeev | Chief Medical Officer | Option exercise | 3,530 | — |
| 2026-10-09 | Saggar Rajeev | Chief Medical Officer | Option exercise | 4,486 | — |
| 2026-10-09 | Moomaw Scott | Chief Commercial Officer | Option exercise | 3,108 | — |
| 2026-10-09 | Moomaw Scott | Chief Commercial Officer | Option exercise | 4,358 | — |
| 2026-10-09 | Krepp Sarah | Chief Human Resource Officer | Option exercise | 3,178 | — |
| 2026-10-09 | Kaseta Michael | CFO and COO | Option exercise | 5,828 | — |
| 2026-10-09 | Kaseta Michael | CFO and COO | Option exercise | 7,049 | — |
| 2026-10-09 | JEFFS ROGER | Chief Executive Officer | Option exercise | 13,833 | — |
| 2026-10-09 | JEFFS ROGER | Chief Executive Officer | Option exercise | 14,333 | — |
| 2026-10-09 | Boyle Dana | Chief Accounting Officer | Option exercise | 3,178 | — |
| 2026-10-09 | Adair Jason | Chief Business Officer | Option exercise | 3,906 | — |
| 2026-10-09 | Adair Jason | Chief Business Officer | Option exercise | 2,474 | — |
| 2026-10-09 | Adair Jason | Chief Business Officer | Option exercise | 3,868 | — |
| 2026-10-05 | Bloch Stephen M | Director | Open market sale | 235,477 | $27.13 |
| 2026-09-14 | SINGH RAMAN | Director | Option exercise | 8,468 | $9.31 |
| 2026-09-14 | SINGH RAMAN | Director | Open market sale | 8,468 | $66.16 |
| 2026-09-11 | SINGH RAMAN | Director | Option exercise | 556 | $8.63 |
| 2026-09-11 | SINGH RAMAN | Director | Option exercise | 8,468 | $9.31 |
| 2026-09-11 | SINGH RAMAN | Director | Open market sale | 9,024 | $68.62 |
| 2026-09-01 | Krepp Sarah | Chief Human Resource Officer | Open market sale | 274 | $67.76 |
| 2026-08-21 | Adair Jason | Chief Business Officer | Option exercise | 9,000 | $9.31 |
| 2026-08-21 | Adair Jason | Chief Business Officer | Option exercise | 11,799 | $9.31 |
| 2026-08-21 | Adair Jason | Chief Business Officer | Option exercise | 10,762 | $14.20 |
| 2026-08-21 | Adair Jason | Chief Business Officer | Option exercise | 238 | $14.20 |
| 2026-08-21 | Adair Jason | Chief Business Officer | Open market sale | 31,799 | $69.09 |
| 2026-08-21 | Adair Jason | Chief Business Officer | Open market sale | 41,832 | $69.09 |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Option exercise | 11,727 | $2.51 |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Option exercise | 6,666 | $2.59 |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Open market sale | 18,393 | $72.23 |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Option exercise | 23,455 | $2.51 |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Option exercise | 13,334 | $2.59 |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Open market sale | 36,789 | $74.99 |
| 2026-08-19 | Saggar Rajeev | Chief Medical Officer | Option exercise | 50,000 | $3.73 |
| 2026-08-19 | Saggar Rajeev | Chief Medical Officer | Open market sale | 50,000 | $74.06 |
| 2026-08-17 | Saggar Rajeev | Chief Medical Officer | Open market sale | 29,534 | $76.84 |
| 2026-07-27 | Boyle Dana | Chief Accounting Officer | Open market sale | 1,600 | $87.53 |
| 2026-07-27 | Adair Jason | Chief Business Officer | Open market sale | 688 | $87.53 |
| 2026-07-23 | Bloch Stephen M | Director | Open market sale | 96,400 | $89.44 |
| 2026-07-23 | Bloch Stephen M | Director | Open market sale | 3,600 | $90.71 |
| 2026-07-22 | Bloch Stephen M | Director | Open market sale | 37,406 | $87.70 |
| 2026-07-22 | Bloch Stephen M | Director | Open market sale | 48,032 | $88.65 |
| 2026-07-22 | Bloch Stephen M | Director | Open market sale | 14,562 | $89.24 |
| 2026-07-21 | Bloch Stephen M | Director | Open market sale | 74,444 | $79.98 |
| 2026-07-21 | Bloch Stephen M | Director | Open market sale | 556 | $80.66 |
| 2026-07-20 | Bloch Stephen M | Director | Open market sale | 3,596 | $79.55 |
| 2026-07-13 | Krepp Sarah | Chief Human Resource Officer | Open market sale | 558 | $71.39 |
| 2026-07-13 | Krepp Sarah | Chief Human Resource Officer | Open market sale | 7,306 | $71.52 |
| 2026-07-13 | Khindri Sanjeev | Chief Development Officer | Open market sale | 84 | $71.39 |
| 2026-07-13 | Khindri Sanjeev | Chief Development Officer | Open market sale | 1,101 | $71.52 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-14 21:29 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-14 | 8-K | 2026-10-08 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-12 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-07 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-09-30 | 8-K | 2026-09-30 | View on SEC.gov → |
Recent news
Headlines about LQDA (Liquidia Corporation). Links open the publisher — we don’t host full articles.
-
Liquidia soars 27% after settlement resolves litigation
Seeking Alpha · 2026-10-14 -
Liquidia soars 27% after settlement resolves litigation (LQDA:NASDAQ)
Seeking Alpha · 2026-10-14 -
Sector Update: Healthcare Stocks Gain Late Afternoon
Yahoo Finance · 2026-10-14 -
Liquidia (NASDAQ:LQDA) Stock Sees Heavy Call Option Buying
MarketBeat · 2026-10-14 -
Liquidia shares jump 25% after settling patent lawsuits with United Therapeutics
Pluang · 2026-10-14 -
Liquidia surges as United Therapeutics settlement removes key litigation risk
Reuters · 2026-10-14 -
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label
Yahoo Finance · 2026-10-14 -
Top movers analysis in the middle of the day on 2026-10-14: top gainers and losers in today's session.
ChartMill · 2026-10-14
No headlines in this category right now — try “All”.